Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Earnings
Ansys cuts FY20 EPS view to $5.61-$6.23 from $6.19-$6.71, consensus $6.26 » 17:05
05/06/20
05/06
17:05
05/06/20
17:05
ANSS

Ansys

$268.49 /

+5.89 (+2.24%)

Cuts FY20 revenue view to…

Cuts FY20 revenue view to $1.54B-$1.56B from $1.64B-$1.7B, consensus $1.64B.

ShowHide Related Items >><<
ANSS Ansys
$268.49 /

+5.89 (+2.24%)

03/13/20 Wedbush
Ansys price target lowered to $249 from $295 at Wedbush
02/19/20 Baird
Ansys assumed with an Outperform at Baird
02/10/20 Citi
Ansys downgraded to Neutral from Buy at Citi (Friday)
02/07/20 Citi
Ansys downgraded to Neutral from Buy at Citi
Earnings
Ansys sees Q2 EPS $1.01-$1.33, consensus $1.43 » 17:02
05/06/20
05/06
17:02
05/06/20
17:02
ANSS

Ansys

$268.49 /

+5.89 (+2.24%)

Sees Q2 revenue…

Sees Q2 revenue $330.9M-$370.9M, consensus $382.7M.

ShowHide Related Items >><<
ANSS Ansys
$268.49 /

+5.89 (+2.24%)

03/13/20 Wedbush
Ansys price target lowered to $249 from $295 at Wedbush
02/19/20 Baird
Ansys assumed with an Outperform at Baird
02/10/20 Citi
Ansys downgraded to Neutral from Buy at Citi (Friday)
02/07/20 Citi
Ansys downgraded to Neutral from Buy at Citi
Earnings
Ansys reports Q1 EPS 83c, consensus 80c » 17:01
05/06/20
05/06
17:01
05/06/20
17:01
ANSS

Ansys

$268.49 /

+5.89 (+2.24%)

Reports Q1 revenue…

Reports Q1 revenue $304.99M, consensus $310.83M. Ajei Gopal, Ansys president and CEO, stated, "I am very proud that the Ansys team has come together, despite working remotely, to close deals and to continue providing outstanding support to our customers. That effort, in the face of uncertain global economic conditions, has led to Ansys delivering financial results near the midpoint of our guidance. We have also continued to drive innovation across our multiphysics portfolio through organic product development seen in Ansys 2020 Release 1 as well as through acquisitions."

ShowHide Related Items >><<
ANSS Ansys
$268.49 /

+5.89 (+2.24%)

03/13/20 Wedbush
Ansys price target lowered to $249 from $295 at Wedbush
02/19/20 Baird
Ansys assumed with an Outperform at Baird
02/10/20 Citi
Ansys downgraded to Neutral from Buy at Citi (Friday)
02/07/20 Citi
Ansys downgraded to Neutral from Buy at Citi
Over a month ago
Hot Stocks
Ansys sees 'great liquidity as well as access to credit' if needed » 14:07
04/02/20
04/02
14:07
04/02/20
14:07
ANSS

Ansys

$211.97 /

+0.71 (+0.34%)

Ansys announced that it…

Ansys announced that it issued an open letter to its investors amid the coronavirus disease 2019 pandemic, in which the company stated in part: "At the onset of the crisis, Ansys took action to enable our employees to work from home as we closed our offices first in China, followed by other locations around the world. As I write to you now at the end of March, the improving situation in China has led us to reopen all our offices there...Smaller, less insulated companies are at risk or have already gone out of business. We are all moved by the stories of our neighbors and family members who have lost their jobs as a result of this pandemic. At Ansys though, we are continuing to pay all our salaried and hourly workers. And based on today's circumstances, we are not planning any job actions...Thanks to our fiscal discipline, we have a strong balance sheet, great liquidity as well as access to credit, when and if we need it. Also, as a reminder, 77% of Ansys' annual contract value last year was of a recurring nature, meaning customers continued to pay for access to our simulation technology and ongoing enhancements. It is also important to remember that our business is highly diversified, both from a vertical and a geographical perspective. Our strength across multiple industries, including high-technology, aerospace and defense, automotive, industrial equipment and energy helps to insulate us against a downturn in specific markets. Similarly, about 40% of our revenue comes from North America with the rest split roughly evenly between Asia and Europe. These are unpredictable times and the extent of the economic impact of the pandemic is still uncertain. But with the precautions we are taking for our employees' health and safety, our investments in infrastructure and collaboration technologies, special accommodations for our customers and our continued fiscal discipline, I believe Ansys is well positioned to help our customers during this critical time - and well into the future."

ShowHide Related Items >><<
ANSS Ansys
$211.97 /

+0.71 (+0.34%)

03/13/20 Wedbush
Ansys price target lowered to $249 from $295 at Wedbush
02/19/20 Baird
Ansys assumed with an Outperform at Baird
02/10/20 Citi
Ansys downgraded to Neutral from Buy at Citi (Friday)
02/07/20 Citi
Ansys downgraded to Neutral from Buy at Citi
Recommendations
Ansys price target lowered to $249 from $295 at Wedbush » 07:49
03/13/20
03/13
07:49
03/13/20
07:49
ANSS

Ansys

$204.00 /

-14.6 (-6.68%)

Wedbush analyst Steve…

Wedbush analyst Steve Koenig lowered the firm's price target on Ansys to $249 from $295 and keeps an Outperform rating on the shares after traveling with management in Boston, saying management hasn't seen any change to its business since it provided Q1 and FY20 guidance on its Q4 call on February 27. Koenig says management told him that its China organization has renewed normal operations and conveyed confidence in the outlook for continuing adoption of the company's leading-edge simulation technology.

ShowHide Related Items >><<
ANSS Ansys
$204.00 /

-14.6 (-6.68%)

02/19/20 Baird
Ansys assumed with an Outperform at Baird
02/10/20 Citi
Ansys downgraded to Neutral from Buy at Citi (Friday)
02/07/20 Citi
Ansys downgraded to Neutral from Buy at Citi
01/02/20 Needham
Ansys downgraded to Hold from Buy at Needham
Conference/Events
Berenberg to hold a conference » 08:28
03/12/20
03/12
08:28
03/12/20
08:28
ALTR

Altair

$29.26 /

-0.84 (-2.79%)

, ANSS

Ansys

$218.60 /

-9.96 (-4.36%)

, AZPN

Aspen Technology

$94.92 /

-0.64 (-0.67%)

, FARO

Faro Technologies

$49.62 /

-3.64 (-6.83%)

, HXGBY

Hexagon AB

$0.00 /

+ (+0.00%)

, PTC

PTC

$59.71 /

-1.32 (-2.16%)

, SAP

SAP

$112.51 /

-5.53 (-4.68%)

, SNPS

Synopsys

$131.86 /

-3.42 (-2.53%)

Design Software…

Design Software Conference to be held in New York on March 12.

ShowHide Related Items >><<
ALTR Altair
$29.26 /

-0.84 (-2.79%)

01/23/20 Guggenheim
Guggenheim thinks consensus forecasts for Altair too high, downgrades to Sell
01/23/20 Guggenheim
Altair downgraded to Sell from Neutral at Guggenheim
01/17/20 Needham
Altair price target raised to $44 from $38 at Needham
11/12/19 Goldman Sachs
Altair initiated with a Neutral at Goldman Sachs
ANSS Ansys
$218.60 /

-9.96 (-4.36%)

02/19/20 Baird
Ansys assumed with an Outperform at Baird
02/10/20 Citi
Ansys downgraded to Neutral from Buy at Citi (Friday)
02/07/20 Citi
Ansys downgraded to Neutral from Buy at Citi
01/02/20 Needham
Ansys downgraded to Hold from Buy at Needham
AZPN Aspen Technology
$94.92 /

-0.64 (-0.67%)

01/31/20 Baird
Aspen Technology weakness a buying opportunity, says Baird
01/14/20 Wedbush
Aspen Technology price target raised to $154 from $145 at Wedbush
12/06/19
Aspen Technology management to meet with Benchmark
09/11/19 JPMorgan
Aspen Technology assumed with an Underweight at JPMorgan
FARO Faro Technologies
$49.62 /

-3.64 (-6.83%)

02/21/20
Faro Technologies upgraded to Buy from Hold at Craig-Hallum
02/21/20 Craig-Hallum
Faro Technologies upgraded to Buy from Hold at Craig-Hallum
11/01/19 Gabelli
Gabelli downgrades Faro Technologies on weakness in 3D markets
10/31/19 Gabelli
Faro Technologies downgraded to Hold from Buy at Gabelli
HXGBY Hexagon AB
$0.00 /

+ (+0.00%)

PTC PTC
$59.71 /

-1.32 (-2.16%)

03/11/20 RBC Capital
PTC price target lowered to $67 from $83 at RBC Capital
03/11/20 Wedbush
PTC price target lowered to $68 from $86 at Wedbush
02/19/20 Stifel
Rockwell Automation deal for Kalypso a 'net-positive' for PTC, says Stifel
02/19/20 Baird
PTC assumed with an Outperform at Baird
SAP SAP
$112.51 /

-5.53 (-4.68%)

02/14/20 Piper Sandler
BlackLine upgraded to Overweight from Neutral at Piper Sandler
02/11/20 JMP Securities
BlackLine price target raised to $69 from $60 at JMP Securities
01/29/20 RBC Capital
SAP price target lowered to $157 from $167 at RBC Capital
01/24/20 Goldman Sachs
SAP price target raised to $196 from $168 at Goldman Sachs
SNPS Synopsys
$131.86 /

-3.42 (-2.53%)

02/20/20 DA Davidson
Synopsys price target raised to $200 from $175 at DA Davidson
02/20/20 Credit Suisse
Synopsys price target raised to $180 from $150 at Credit Suisse
02/20/20 KeyBanc
Synopsys price target raised to $175 from $160 at KeyBanc
02/18/20 Baird
Synopsys initiated with an Outperform at Baird
Conference/Events
Ansys management to meet with Wedbush » 04:55
03/11/20
03/11
04:55
03/11/20
04:55
ANSS

Ansys

$228.56 /

+6.14 (+2.76%)

Meeting to be held in…

Meeting to be held in Boston on March 11 hosted by Wedbush.

ShowHide Related Items >><<
ANSS Ansys
$228.56 /

+6.14 (+2.76%)

02/19/20 Baird
Ansys assumed with an Outperform at Baird
02/10/20 Citi
Ansys downgraded to Neutral from Buy at Citi (Friday)
02/07/20 Citi
Ansys downgraded to Neutral from Buy at Citi
01/02/20 Needham
Ansys downgraded to Hold from Buy at Needham
Conference/Events
Ansys management to meet with Wedbush » 08:07
03/09/20
03/09
08:07
03/09/20
08:07
ANSS

Ansys

$237.95 /

-10.21 (-4.11%)

Meeting to be held in…

Meeting to be held in Boston on March 11 hosted by Wedbush.

ShowHide Related Items >><<
ANSS Ansys
$237.95 /

-10.21 (-4.11%)

02/19/20 Baird
Ansys assumed with an Outperform at Baird
02/10/20 Citi
Ansys downgraded to Neutral from Buy at Citi (Friday)
02/07/20 Citi
Ansys downgraded to Neutral from Buy at Citi
01/02/20 Needham
Ansys downgraded to Hold from Buy at Needham
Hot Stocks
Ansys to acquire Lumerical, terms not disclosed » 09:30
03/05/20
03/05
09:30
03/05/20
09:30
ANSS

Ansys

$259.49 /

+10.62 (+4.27%)

Ansys announced that it…

Ansys announced that it has entered into a definitive agreement to acquire Lumerical, "a leading developer of photonic design and simulation tools." The acquisition will add best-in-class photonics products to the Ansys multiphysics portfolio, providing customers with a full set of solutions to solve their next-generation product challenges. The transaction is subject to the satisfaction of customary closing conditions and is expected to close in the second quarter of 2020. It is not expected to have a material impact on Ansys' consolidated financial statements in 2020.

ShowHide Related Items >><<
ANSS Ansys
$259.49 /

+10.62 (+4.27%)

02/19/20 Baird
Ansys assumed with an Outperform at Baird
02/10/20 Citi
Ansys downgraded to Neutral from Buy at Citi (Friday)
02/07/20 Citi
Ansys downgraded to Neutral from Buy at Citi
01/02/20 Needham
Ansys downgraded to Hold from Buy at Needham
Over a quarter ago
Hot Stocks
Fly Intel: After Hours Movers » 19:03
02/26/20
02/26
19:03
02/26/20
19:03
SPT

Sprout Social

$17.70 /

-1.11 (-5.90%)

, TDOC

Teladoc

$116.89 /

-1.55 (-1.31%)

, AKRX

Akorn

$1.29 /

-0.04 (-3.02%)

, ALIM

Alimera Sciences

$6.38 /

-0.06 (-0.93%)

, ETSY

Etsy

$50.64 /

+0.73 (+1.46%)

, ESTC

Elastic

$63.78 /

-2.235 (-3.39%)

, DDD

3D Systems

$10.24 /

-0.355 (-3.35%)

, BOX

Box

$14.98 /

-0.075 (-0.50%)

, NTRA

Natera

$34.76 /

-0.2 (-0.57%)

, CPE

Callon Petroleum

$2.21 /

-0.14 (-5.96%)

, UPWK

Upwork

$8.13 /

-0.19 (-2.28%)

, SQ

Square

$76.63 /

-0.38 (-0.49%)

, CLW

Clearwater Paper

$26.98 /

+0.71 (+2.70%)

, RUBI

Rubicon Project

$11.03 /

-0.6 (-5.16%)

, NDLS

Noodles & Company

$7.90 /

-0.35 (-4.24%)

, OPK

Opko Health

$1.39 /

-0.005 (-0.36%)

, ARNA

Arena Pharmaceuticals

$46.98 /

-0.93 (-1.94%)

, ACAD

Acadia

$40.30 /

-0.37 (-0.91%)

, SWX

Southwest Gas

$71.84 /

-2.02 (-2.73%)

, CLGX

CoreLogic

$48.39 /

+ (+0.00%)

, QGEN

Qiagen

$35.08 /

+0.09 (+0.26%)

, GILD

Gilead

$74.70 /

+4.57 (+6.52%)

, CLR

Continental Resources

$20.79 /

-1.125 (-5.13%)

, NTNX

Nutanix

$32.65 /

-2.08 (-5.99%)

, TPC

Tutor Perini

$11.99 /

+0.46 (+3.99%)

, QEP

QEP Resources

$2.16 /

-0.105 (-4.64%)

, MED

Medifast

$94.05 /

-1.09 (-1.15%)

, CVNA

Carvana

$101.66 /

-2.535 (-2.43%)

, LHCG

LHC Group

$150.40 /

+1.81 (+1.22%)

, FRGI

Fiesta Restaurant

$9.07 /

-0.91 (-9.12%)

, CCI

Crown Castle

$162.74 /

-0.33 (-0.20%)

, PTLA

Portola Pharmaceuticals

$12.51 /

-0.13 (-1.03%)

, PDCE

PDC Energy

$18.48 /

-1 (-5.13%)

, ANSS

Ansys

$273.00 /

+6.64 (+2.49%)

, SILK

Silk Road Medical

$45.25 /

-1.29 (-2.77%)

, RGNX

Regenxbio

$47.50 /

+0.13 (+0.27%)

, LB

L Brands

$22.77 /

-0.76 (-3.23%)

, NTES

NetEase

$345.55 /

+7.47 (+2.21%)

, BKNG

Booking Holdings

$1,683.38 /

-44.63 (-2.58%)

, MSFT

Microsoft

$170.20 /

+2.14 (+1.27%)

UP AFTER EARNINGS: Sprout…

UP AFTER EARNINGS: Sprout Social (SPT) up 18.6%... Teladoc (TDOC) up 17.2%... Akorn (AKRX) down 12.7%... Alimera Sciences (ALIM) up 11.5%... Etsy (ETSY) up 10.6%... Elastic (ESTC) up 10.5%... 3D Systems (DDD) up 9.2%... Box Inc (BOX) up 8.8%... Natera (NTRA) up 8.7%... Callon Petroleum (CPE) up 8.1%... Upwork (UPWK) up 8.0%... Square (SQ) up 7.4%... Clearwater Paper (CLW) up 5.6%... Rubicon Project (RUBI) up 5.5%... Noodles & Co (NDLS) up 5.4%... Opko Health (OPK) up 5.1%... Arena Pharma (ARNA) up 4.5%... Acadia Pharma (ACAD) up 4.1%... Southwest Gas (SWX) up 4.0%... Corelogic (CLGX) up 2.1%. ALSO HIGHER: Qiagen (QGEN) up 3.3% after announcing shipments of coronavirus test kits... Gilead (GILD) up 3.0% after initiating two phase 3 studies of antiviral Remdesivir in coronavirus. DOWN AFTER EARNINGS: Continental Resources (CLR) down 17.0%... Nutanix (NTNX) down 16.0%... Tutor Perini (TPC) down 15.8%... QEP Resources (QEP) down 14.8%... Medifast (MED) down 14.3%... Carvana (CVNA) down 10.7%... LHC Group (LHCG) down 6.9%... Fiesta Restaurant (FRGI) down 6.6%... Crown Castle (CCI) down 5.7%... Portola Pharma (PTLA) down 5.2%... PDC Energy (PDCE) down 5.0%... Ansys (ANSS) down 3.8%... Silk Road Medical (SILK) down 2.5%... Regenexbio (RGNX) down 2.3%... L Brands (LB) down 2.1%... NetEase (NTES) down 1.7%... Booking Holdings (BKNG) down 0.5%. ALSO LOWER: Microsoft (MSFT) down 1.4% after saying will not meet Q3 guidance in More Personal Computing segment. Movers as of 18:30ET.

ShowHide Related Items >><<
SPT Sprout Social
$17.70 /

-1.11 (-5.90%)

01/07/20 Morgan Stanley
Sprout Social initiated with an Overweight at Morgan Stanley
01/07/20 KeyBanc
Sprout Social initiated with an Overweight at KeyBanc
01/07/20 Goldman Sachs
Sprout Social initiated with a Buy at Goldman Sachs
01/07/20 Stifel
Sprout Social initiated with a Buy at Stifel
TDOC Teladoc
$116.89 /

-1.55 (-1.31%)

02/12/20
Fly Intel: Top five analyst downgrades
02/12/20 Wells Fargo
Teladoc downgraded to Equal Weight on valuation at Wells Fargo
02/12/20 Wells Fargo
Teladoc downgraded to Equal Weight from Overweight at Wells Fargo
01/21/20 RBC Capital
Teladoc price target raised to $110 from $100 at RBC Capital
AKRX Akorn
$1.29 /

-0.04 (-3.02%)

01/13/20 Cantor Fitzgerald
Report of Perrigo buying Akorn 'not likely true,' says Cantor Fitzgerald
12/19/19 Raymond James
Media attention 'mainstreamed' idea of Akorn bankruptcy, says Raymond James
12/18/19 Gabelli
Akorn's ability to avoid bankruptcy remains in limbo, says Gabelli
05/08/19 RBC Capital
Akorn price target raised to $5 from $4 at RBC Capital
ALIM Alimera Sciences
$6.38 /

-0.06 (-0.93%)

01/08/20 B. Riley FBR
B. Riley FBR highlights six Specialty Pharma stocks for 2020
09/30/19 B. Riley FBR
Alimera checks show 'substantial' recovery in Q3, says B. Riley FBR
05/28/19 Craig-Hallum
Alimera Sciences initiated with a Buy at Craig-Hallum
ETSY Etsy
$50.64 /

+0.73 (+1.46%)

02/06/20 Jefferies
Etsy initiated with a Hold at Jefferies
12/13/19 SunTrust
Etsy initiated with a Buy at SunTrust
12/13/19 SunTrust
Etsy initiated with a Buy at SunTrust
12/05/19
Fly Intel: Top five analyst downgrades
ESTC Elastic
$63.78 /

-2.235 (-3.39%)

01/09/20 Jefferies
Elastic upgraded to Buy from Hold at Jefferies
01/06/20 Oppenheimer
Oppenheimer remains bullish on Elastic, views as a top pick
12/19/19 Jefferies
Elastic share risk/reward remains balanced, says Jefferies
12/05/19 RBC Capital
Elastic price target lowered to $103 from $117 at RBC Capital
DDD 3D Systems
$10.24 /

-0.355 (-3.35%)

01/28/20
Fly Intel: Top five analyst downgrades
01/28/20 Piper Sandler
Reseller survey shows mixed 3D printing demand in Q4, says Piper Sandler
01/28/20 Piper Sandler
3D Systems downgraded to Neutral from Overweight at Piper Sandler
01/16/20
3D Systems downgraded to Sell from Hold at Loop Capital
BOX Box
$14.98 /

-0.075 (-0.50%)

12/19/19 Gordon Haskett
Dropbox up 8%, Gordon Haskett says could draw 'special situation interest'
11/27/19 Wells Fargo
Box price target raised to $22 from $20 at Wells Fargo
11/12/19
Fly Intel: Top five analyst downgrades
11/12/19 JMP Securities
Box downgraded to Market Perform from Outperform at JMP Securities
NTRA Natera
$34.76 /

-0.2 (-0.57%)

12/19/19 Craig-Hallum
Natera kidney test to be covered under Medicare in February, says Craig-Hallum
12/19/19 Piper Sandler
CareDx should be bought on weakness from Natera coverage, says Piper
11/11/19 Canaccord
Natera results solid, remains a top pick at Canaccord
11/07/19 Craig-Hallum
Natera price target raised to $49 from $37 at Craig-Hallum
CPE Callon Petroleum
$2.21 /

-0.14 (-5.96%)

02/05/20 Barclays
Callon Petroleum downgraded to Equal Weight from Overweight at Barclays
01/23/20 Credit Suisse
Credit Suisse says 'moving to the sidelines' on Callon Petroleum
01/22/20 Credit Suisse
Callon Petroleum downgraded to Neutral from Outperform at Credit Suisse
12/23/19 Imperial Capital
Callon Petroleum price target raised to $13 from $10 at Imperial Capital
UPWK Upwork
$8.13 /

-0.19 (-2.28%)

01/24/20 Guggenheim
Upwork downgraded to Neutral on slowing growth at Guggenheim
01/24/20 Guggenheim
Upwork downgraded to Neutral from Buy at Guggenheim
01/02/20
Fly Intel: Top five analyst downgrades
01/02/20 Citi
Upwork downgraded to Neutral from Buy at Citi
SQ Square
$76.63 /

-0.38 (-0.49%)

02/24/20 KeyBanc
Credit Karma potential deal shows rising importance of FinApps, says KeyBanc
02/21/20 Citi
Square price target raised to $99 from $80 at Citi
02/03/20 Northland
Square partnership a net negative for Stamps.com, says Northland
01/30/20 Keefe Bruyette
Square pact with UPS may help compete with Shopify, says Keefe Bruyette
CLW Clearwater Paper
$26.98 /

+0.71 (+2.70%)

01/14/20 RBC Capital
Clearwater Paper upgraded to Sector Perform from Underperform at RBC Capital
08/01/19
Clearwater Paper cut to Underperform at RBC Capital on leverage and labor issues
08/01/19 RBC Capital
Clearwater Paper downgraded to Underperform from Sector Perform at RBC Capital
03/14/19 DA Davidson
Clearwater Paper price target lowered to $44 from $57 at DA Davidson
RUBI Rubicon Project
$11.03 /

-0.6 (-5.16%)

01/15/20 Stephens
Google cookie announcement widely anticipated, concerns overblown, says Stephens
01/14/20 SunTrust
SunTrust sees little disruption to Rubicon following Google cookie news
01/09/20 Craig-Hallum
Rubicon Project, Telaria shares can continue to move higher, says Craig-Hallum
12/20/19 Craig-Hallum
Rubicon Project, Telaria price targets raised at Craig-Hallum after merger news
NDLS Noodles & Company
$7.90 /

-0.35 (-4.24%)

02/14/20 Maxim
Noodles & Company initiated with a Buy at Maxim
02/14/20 Maxim
Noodles & Company initiated with a Buy at Maxim
12/10/19 Jefferies
Burger King, Dunkin, Del Taco best positioned QSRs for alt meats, says Jefferies
10/17/19 Jefferies
Noodles & Company same-sale-sales momentum continued in Q3, says Jefferies
OPK Opko Health
$1.39 /

-0.005 (-0.36%)

11/25/19 Piper Sandler
Opko Health initiated with an Overweight at Piper Jaffray
10/22/19 Wedbush
Ascendis Pharma price target lowered to $186 from $191 at Wedbush
06/27/19 Jefferies
Novitas reverses decision in positive suprise for Opko Health, says Jefferies
05/08/19 Barrington
Barrington keeps Outperform rating on Opko Health after Q1 report
ARNA Arena Pharmaceuticals
$46.98 /

-0.93 (-1.94%)

01/31/20 JPMorgan
JPMorgan upgrades Arena Pharmaceuticals ahead of 'catalyst rich' two years
01/31/20 JPMorgan
Arena Pharmaceuticals upgraded to Overweight from Neutral at JPMorgan
01/08/20 JMP Securities
Arena Pharmaceuticals has right management team in place, says JMP Securities
11/13/19 BofA
Arena Pharmaceuticals initiated with a Neutral at BofA/Merrill
ACAD Acadia
$40.30 /

-0.37 (-0.91%)

12/23/19 Stifel
Stifel sees Intra-Cellular's Lumateperone approval as bullish for CNS stocks
12/18/19 JPMorgan
BioMarin, Vertex among JPMorgan's top Biotech picks for 2020
12/16/19 Guggenheim
Acadia initiated with a Buy at Guggenheim
12/05/19 Piper Sandler
Acadia's dementia-related psychosis data 'a clear win,' says Piper Jaffray
SWX Southwest Gas
$71.84 /

-2.02 (-2.73%)

01/31/20 UBS
Southwest Gas price target lowered to $83 from $96 at UBS
07/17/19 JPMorgan
Southwest Gas initiated with an Overweight at JPMorgan
03/29/19 UBS
Southwest Gas downgraded to Neutral from Buy at UBS
03/29/19 UBS
Southwest Gas downgraded to Neutral from Buy at UBS
CLGX CoreLogic
$48.39 /

+ (+0.00%)

10/25/19 Wolfe Research
CoreLogic downgraded to Peer Perform from Outperform at Wolfe Research
10/24/19 Deutsche Bank
Deutsche Bank downgrades CoreLogic to Sell on 'worsening headwinds'
10/24/19 Deutsche Bank
CoreLogic downgraded to Sell from Hold at Deutsche Bank
08/21/19
Fly Intel: Top five analyst initiations
QGEN Qiagen
$35.08 /

+0.09 (+0.26%)

02/05/20 Piper Sandler
Qiagen price target raised to $36 from $29 at Piper Sandler
01/07/20 Wells Fargo
Qiagen initiated with an Equal Weight at Wells Fargo
01/06/20 Citi
Qiagen initiated with a Neutral at Citi
01/06/20 Commerzbank
Qiagen downgraded to Hold from Buy at Commerzbank
GILD Gilead
$74.70 /

+4.57 (+6.52%)

02/25/20 Stifel
Iovance among 'more interesting' cell therapy takeout candidates, says Stifel
02/24/20 SunTrust
SunTrust says Gilead's remdesivir unlikely to add to topline
02/24/20 BofA
BofA stays cautious on Gilead as remdesivir hope drives shares higher
02/24/20 Stifel
Galapagos price target raised to $298 from $188 at Stifel
CLR Continental Resources
$20.79 /

-1.125 (-5.13%)

12/17/19 Goldman Sachs
Goldman Sachs downgrades Continental Resources to Sell on 'too rich' valuation
12/17/19 Goldman Sachs
Continental Resources downgraded to Sell from Neutral at Goldman Sachs
10/10/19
Fly Intel: Top five analyst downgrades
10/10/19 Mizuho
Continental Resources downgraded to Neutral from Buy at Mizuho
NTNX Nutanix
$32.65 /

-2.08 (-5.99%)

02/24/20 RBC Capital
Nutanix price target raised to $42 from $38 at RBC Capital
02/03/20 RBC Capital
Nutanix promotion of Chris Kaddaras a 'positive' indicator, says RBC Capital
01/15/20 Piper Sandler
Piper introduces long VMware, short Juniper pair trade into Q4 results
11/26/19 Baird
Nutanix price target raised to $38 from $29 at Baird
TPC Tutor Perini
$11.99 /

+0.46 (+3.99%)

11/07/19 B. Riley FBR
Tutor Perini price target raised to $23 from $18 at B. Riley FBR
08/12/19 DA Davidson
Tutor Perini price target lowered to $18 from $22 at DA Davidson
07/01/19 DA Davidson
Tutor Perini upgraded to Buy from Neutral at DA Davidson
07/01/19 DA Davidson
Tutor Perini upgraded to Buy from Neutral at DA Davidson
QEP QEP Resources
$2.16 /

-0.105 (-4.64%)

10/30/19 Stephens
QEP Resources upgraded to Overweight on successful execution at Stephens
10/30/19 Stephens
QEP Resources upgraded to Overweight from Equal Weight at Stephens
10/28/19 Piper Sandler
QEP Resources upgraded to Overweight from Neutral at Piper Jaffray
10/24/19 Williams Capital
QEP Resources upgraded to Buy from Hold at Williams Capital
MED Medifast
$94.05 /

-1.09 (-1.15%)

01/14/20 Jefferies
Medifast price target raised to $130 from $110 at Jefferies
12/20/19 Jefferies
Potential activist-led bid for Medifast reinforces value gap, says Jefferies
11/08/19 DA Davidson
Medifast cut to Neutral at DA Davidson on business disruption
11/08/19 DA Davidson
Medifast downgraded to Neutral from Buy at DA Davidson
CVNA Carvana
$101.66 /

-2.535 (-2.43%)

02/25/20 B. Riley FBR
Carvana price target raised to $125 from $91 at B. Riley FBR
02/24/20
Fly Intel: Top five analyst initiations
02/24/20 Deutsche Bank
Carvana initiated with a Hold at Deutsche Bank
02/06/20 Evercore ISI
Carvana initiated with an In Line at Evercore ISI
LHCG LHC Group
$150.40 /

+1.81 (+1.22%)

12/06/19 SunTrust
LHC Group price target raised to $160 from $145 at SunTrust
11/01/19 William Blair
Home health 2020 rate final rule positive for providers, says William Blair
10/21/19 Stephens
LHC Group resumed with an Overweight at Stephens
09/16/19 Deutsche Bank
LHC Group initiated with a Buy at Deutsche Bank
FRGI Fiesta Restaurant
$9.07 /

-0.91 (-9.12%)

08/08/19 Stephens
Fiesta Restaurant price target lowered to $14 from $25 at Stephens
CCI Crown Castle
$162.74 /

-0.33 (-0.20%)

02/11/20 KeyBanc
T-Mobile, Sprint merger approval negative for Verizon/AT&T, says KeyBanc
01/16/20 Barclays
Crown Castle initiated with an Overweight at Barclays
01/13/20 Goldman Sachs
SBA Communications upgraded to Buy from Neutral at Goldman Sachs
01/10/20 KeyBanc
American Tower price target raised to $254 from $242 at KeyBanc
PTLA Portola Pharmaceuticals
$12.51 /

-0.13 (-1.03%)

01/10/20 Cowen
Portola Pharmaceuticals price target lowered to $35 from $45 at Cowen
01/10/20 Oppenheimer
Oppenheimer downgrades Portola on Andexxa headwinds, cuts target to $17
01/10/20 Oppenheimer
Portola Pharmaceuticals downgraded to Perform from Outperform at Oppenheimer
11/08/19 Goldman Sachs
Portola Pharmaceuticals initiated with a Neutral at Goldman Sachs
PDCE PDC Energy
$18.48 /

-1 (-5.13%)

02/14/20 Citi
PDC Energy resumed with a Buy at Citi
01/07/20 Tudor Pickering
PDC Energy upgraded to Buy from Hold at Tudor Pickering
12/09/19 SunTrust
The 21 smaller cap stocks SunTrust sees rallying over 20% in 2020
10/24/19 Roth Capital
SRC Energy downgraded to Neutral at Roth Capital
ANSS Ansys
$273.00 /

+6.64 (+2.49%)

02/19/20 Baird
Ansys assumed with an Outperform at Baird
02/10/20 Citi
Ansys downgraded to Neutral from Buy at Citi (Friday)
02/07/20 Citi
Ansys downgraded to Neutral from Buy at Citi
01/02/20 Needham
Ansys downgraded to Hold from Buy at Needham
SILK Silk Road Medical
$45.25 /

-1.29 (-2.77%)

12/18/19 Stifel
Stifel says Silk Road TCAR data 'highly-encouraging' for boosting TCAR awareness
08/20/19
Fly Intel: Top five analyst initiations
08/20/19 Argus
Silk Road Medical initiated with a Buy at Argus
08/20/19 Argus
Silk Road Medical initiated with a Buy at Argus
RGNX Regenxbio
$47.50 /

+0.13 (+0.27%)

10/14/19 Roth Capital
Ophthalmic therapies 'could go from 0 to 100 real quick,' says Roth Capital
08/20/19 SVB Leerink
Regenxbio upgraded to Market Perform on valuation at SVB Leerink
08/20/19 SVB Leerink
Regenxbio upgraded to Market Perform from Underperform at SVB Leerink
06/13/19 Raymond James
Regenxbio resumed with an Outperform at Raymond James
LB L Brands
$22.77 /

-0.76 (-3.23%)

02/24/20
Fly Intel: Top five analyst downgrades
02/24/20 Goldman Sachs
L Brands price target raised to $28 from $23 at Goldman Sachs
02/24/20 Baird
L Brands downgraded to Neutral from Outperform at Baird
02/21/20 Deutsche Bank
L Brands price target raised to $29 from $24 at Deutsche Bank
NTES NetEase
$345.55 /

+7.47 (+2.21%)

12/04/19
Fly Intel: Top five analyst upgrades
12/04/19 Goldman Sachs
NetEase upgraded to Buy from Neutral at Goldman Sachs
11/25/19 Barclays
NetEase price target raised to $360 from $340 at Barclays
11/22/19 Nomura Instinet
NetEase price target raised to $350 from $317 at Nomura Instinet
BKNG Booking Holdings
$1,683.38 /

-44.63 (-2.58%)

02/26/20 DA Davidson
Booking Holdings price target lowered to $1,775 from $1,875 at DA Davidson
02/20/20 Credit Suisse
Booking Holdings price target lowered to $2,330 from $2,360 at Credit Suisse
02/10/20 Cowen
Investors underestimating coronavirus impact on travel companies. says Cowen
02/03/20 Oppenheimer
Coronavirus a transitory headwind for Booking Holdings, says Oppenheimer
MSFT Microsoft
$170.20 /

+2.14 (+1.27%)

02/04/20 RBC Capital
Slack Technologies initiated with an Outperform at RBC Capital
02/03/20 Bernstein
Amazon Q4 results beat even bullish expectations, says Bernstein
01/31/20 Deutsche Bank
Microsoft price target raised to $200 from $175 at Deutsche Bank
01/31/20 Nomura Instinet
Microsoft price target raised to $195 from $161 at Nomura Instinet

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.